Refractory adult onset Still's disease successfully treated with anakinra
Open Access
- 1 April 2005
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (4) , 647-648
Abstract
We report a favourable response to anakinra in a patient unresponsive to several disease modifying antirheumatic drugs (DMARDs) and TNFα blockers, requiring chronic high doses of steroids. The patient is a 32 year old woman diagnosed at the age 18 with AOSD, defined by the criteria of Yamaguchi et al.10 She was treated with NSAIDs, systemic steroids, and several DMARDs (MTX, sulfasalazine, and ciclosporin A) over a period of 10 years, but she had sustained disease with frequent flares requiring high doses of steroids (up to 1 mg/kg/day).Keywords
This publication has 8 references indexed in Scilit:
- Successful treatment of refractory adult-onset Still?s disease with infliximab. A prospective, non-comparative series of four patientsClinical Rheumatology, 2004
- Biologic therapies for juvenile arthritisArchives of Disease in Childhood, 2003
- Etanercept in the treatment of adult patients with Still's diseaseArthritis & Rheumatism, 2002
- Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular diseaseRheumatology, 2001
- Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritisArthritis & Rheumatism, 2001
- Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritisRheumatology, 1998
- Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2)Rheumatology, 1997
- Methotrexate treatment in patients with adult onset Still's disease—retrospective study of 13 Japanese casesAnnals of the Rheumatic Diseases, 1997